Product Information
VESICARE 5 MG TABLET is a brand product labeled by Astellas Pharma US, Inc., priced at $12.2674 per EA under NDC 51248015001. Its NADAC has been published 526 times since Nov 28, 2013.
FDA first approved this application on Nov 19, 2004.
The High Outlier badge above means this manufacturer's average price in the solifenacin succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
51248015001
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
SOLIFENACIN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA021518FDA Approved
11/19/2004
On Market Since
1/5/2005
Pharmacological Classes
Price Statistics
The NADAC for VESICARE 5 MG TABLET has been published 526 times since Nov 28, 2013, and over the history we have for it it has risen 86.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.2674 per EA |
|---|---|
| All-time high | $12.3695 (Aug 14, 2024) |
| All-time low | $6.5625 (Nov 28, 2013) |
| 52-week high | $12.3183 |
| 52-week low | $12.2613 |
| Median price | $11.6364 |
| Average price | $10.6622 |
| Largest weekly change | +9.9% (Feb 25, 2015) |
| Weeks tracked | 526 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VESICARE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VESICARE 5 MG TABLET, manufactured by Astellas Pharma US, Inc., is $12.2674 per EA (NDC 51248015001), effective Aug 19, 2026.
How has the price of VESICARE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for VESICARE 5 MG TABLET has risen 86.9%. It has been tracked across 526 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VESICARE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for VESICARE 5 MG TABLET has ranged from a low of $6.5625 (Nov 28, 2013) to a high of $12.3695 (Aug 14, 2024), with a median of $11.6364 per EA.
Are there cheaper alternatives to VESICARE 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SOLIFENACIN 5 MG TABLET, is $0.1550 per EA — about 99% below VESICARE 5 MG TABLET.
Who manufactures VESICARE 5 MG TABLET?
VESICARE 5 MG TABLET (NDC 51248015001) is labeled by Astellas Pharma US, Inc., and CMS classifies it as a brand product.